Optimal Ureteral Stent Duration After Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is it safe to use ureteral stents in humans?
Ureteral stents are generally safe for use in humans, but they can cause symptoms that affect quality of life, and prolonged use may lead to complications like infections or blockages. It's important to follow up with healthcare providers to avoid these issues, especially if the stent is placed in an emergency situation.12345
How does the ureteral stent treatment differ from other treatments for ureteral conditions?
Ureteral stents are unique because they are placed inside the ureter (the tube connecting the kidney to the bladder) to help urine flow and relieve blockages, unlike other treatments that may involve surgery or external procedures. The optimal duration for keeping a stent in place is still being studied, as prolonged use can lead to complications like infections or stent fragmentation.45678
What data supports the effectiveness of the treatment Ureteral Stent?
Research shows that the duration of ureteral stent placement can impact the risk of complications. Keeping the stent for more than 30 days after certain procedures increases the chances of infections and other issues, suggesting that the timing of stent removal is important for effectiveness.4891011
Who Is on the Research Team?
Karen Stern, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for individuals who have had a straightforward ureteroscopy, which is a procedure to remove stones from the urinary tract. Participants must be undergoing treatment on one side only, even if they have stones in both sides. Pregnant individuals or those with prior stents, complex procedures, infections, recurrent UTIs, no visible stones during surgery, transplant kidneys or unusual kidney anatomy cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ureteroscopy and stent placement for 3-5 days or 7-9 days
Follow-up
Participants are monitored for symptoms and complications after stent removal
What Are the Treatments Tested in This Trial?
Interventions
- Ureteral Stent
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor